Lu Wen Shi
Director/Board Member chez HOSPITAL CORPORATION OF CHINA LIMITED
Profil
Lu Wen Shi is currently holding multiple positions as Vice Chairman at the Chinese Pharmaceutical Association, Vice Chairman-Pharmacy Administration Professional at the Beijing Association of Chinese Medicine, Independent Director at Beijing Centergate Technologies (Holding) Co., Ltd., Director-International Research Center for Medical at Peking University, Independent Director at China National Medicines Co., Ltd., Independent Non-Executive Director at Hospital Corp.
of China Ltd., Independent Non-Executive Director at DLAB Scientific Co., Ltd., Independent Non-Executive Director at Shandong Boan Biotechnology Co., Ltd., and Independent Non-Executive Director at Sunho Biologics, Inc. He is also a Professor-Department of Pharmacy Administration at Peking University School of Pharmaceutical Sciences.
Dr. Shi has previously worked as a Director at Zhejiang Conba Pharmaceutical Co., Ltd.
from 2017 to 2020 and as an Independent Director at China Meheco Group Co., Ltd.
from 2015 to 2021.
Dr. Shi received his undergraduate degree from Peking University Health Science Center in 1987 and his graduate degree from the University of Illinois in 1992.
Postes actifs de Lu Wen Shi
| Sociétés | Poste | Début |
|---|---|---|
| HOSPITAL CORPORATION OF CHINA LIMITED | Director/Board Member | 13/12/2016 |
| SHANDONG BOAN BIOTECHNOLOGY CO., LTD. | Director/Board Member | 23/03/2021 |
| BEIJING CENTERGATE TECHNOLOGIES (HOLDING) CO., LTD. | Director/Board Member | 22/02/2022 |
| CHINA NATIONAL MEDICINES CORPORATION LTD. | Director/Board Member | 07/04/2022 |
Peking University
 Peking University Other Consumer ServicesConsumer Services Peking University provides post-secondary education services. It offers undergraduate and graduate courses. It provides courses such as basic and applied sciences, social sciences and the humanities, sciences of medicine, management, and education. The company was founded by JiaNai Sun in 1898 and is headquartered in Beijing, China. | Chief Executive Officer | 01/01/2002 |
| Chinese Pharmaceutical Association | Director/Board Member | 01/01/2018 |
| Beijing Association of Chinese Medicine | Corporate Officer/Principal | 01/01/2012 |
| Peking University School of Pharmaceutical Sciences | Corporate Officer/Principal | 01/01/2000 |
DLAB Scientific Co., Ltd.
 DLAB Scientific Co., Ltd. Medical SpecialtiesHealth Technology DLAB Scientific Co., Ltd. is a Chinese company that manufactures laboratory equipment. The company is based in Beijing, China. | Director/Board Member | 01/06/2020 |
| ░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Anciens postes connus de Lu Wen Shi
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░ ░░░░░░ ░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░ ░░░░░░░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Formation de Lu Wen Shi
| University of Illinois | Graduate Degree |
| Peking University Health Science Center | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 6 |
|---|---|
| BEIJING CENTERGATE TECHNOLOGIES (HOLDING) CO., LTD. | Health Technology |
| ZHEJIANG CONBA PHARMACEUTICAL CO.,LTD. | Health Technology |
| CHINA NATIONAL MEDICINES CORPORATION LTD. | Health Technology |
| CHINA MEHECO GROUP CO., LTD. | Health Technology |
| HOSPITAL CORPORATION OF CHINA LIMITED | Health Services |
| SHANDONG BOAN BIOTECHNOLOGY CO., LTD. | Health Technology |
| Entreprise privées | 4 |
|---|---|
| Chinese Pharmaceutical Association | |
| Beijing Association of Chinese Medicine | |
DLAB Scientific Co., Ltd.
DLAB Scientific Co., Ltd. Medical SpecialtiesHealth Technology DLAB Scientific Co., Ltd. is a Chinese company that manufactures laboratory equipment. The company is based in Beijing, China. | Health Technology |
Sunho Biologics, Inc.
 Sunho Biologics, Inc. Miscellaneous Commercial ServicesCommercial Services Sunho Biologics, Inc. is a biopharmaceutical company engages in the development and commercialization of biologics that regulate immune microenvironment by directly modulating both the innate and adaptive immune systems. The company was founded on May 14, 2021 and is headquartered in Huzhou City, China. | Commercial Services |
